- Ad Age, Wednesday, November 2, 2005 1:52 PM
Two days of public hearings on the possible regulation of direct-to-consumer pharmaceutical advertising kicked off Tuesday in Washington. The Food and Drug Administration is hearing lively debate
from both sides of the issue, and even supporters agree it seems clear that some form of changes are in store for the category.
Read the whole story at Ad Age »